India to Ghana: Ceftazidime Export Trade Route

The India to Ghana Ceftazidime corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $2.1M USD. The route is dominated by ZEISS PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's ceftazidime manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $130.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ceftazidime's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #16 among India's top ceftazidime export destinations globally.

On the import side, key buyers of Indian ceftazidime in Ghana include OA&J PHARMACEUTICALS LTD., OA & J PHARMACEUTICALS LTD, OA&J PHARMACEUTICALS LTD. and 7 others. OA&J PHARMACEUTICALS LTD. is the single largest importer with 2 shipments valued at $2.0M USD.

India's ceftazidime exports to Ghana are driven primarily by a handful of large-scale manufacturers. ZEISS PHARMACEUTICALS PRIVATE LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Ghana benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZEISS PHARMACEUTICALS PRIVATE LIMITED, ZEISS PHARMACEUTICALS PRIVATE LIMITED , GRAMEEN PHARMA LLP — together account for 100% of total trade value on this route. The average shipment value of $130.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as inno-zidime 1.0gm ceftazidime for injection usp batch: 19125002 mfg dt: feb,2026 exp dt: jan,2027 and inno-zidime 1.0gm ceftazidime for injection usp batch: 19125001 mfg dt: jan,2025 exp dt: dec,2026, suggesting that buyers in Ghana tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OA&J PHARMACEUTICALS LTD. is the largest importer with 2 shipments worth $2.0M USD — representing 97% of all ceftazidime imports from India on this route. A total of 10 buyers are active on this corridor.